Keenova Therapeutics plc - G5890A102
Sector:
Healthcare
· Industry:
Pharmaceutical Preparations
Website:
No information yet
· Social:
No information yet
Company profile
Description is not available for this instrument yet.
Quarter snapshot
Latest / Compare
Q2 2023
· Q1 2023
Value (USD)
Total reported value ($000)
$6M
QoQ value delta ($000)
-$42.28M
(-87.57%)
Implied price effect (QoQ)
-83.84%
Shares
Total shares
5,094,488
QoQ shares delta
-1,529,381
(-23.09%)
Total shares held by funds (by quarter)
Top holders (Q2 2023)
Top 25 only
Full list
Early Q3 2023 data: only 2 institutional holders reported so far. More will appear as funds file with the SEC.
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| JPMORGAN CHASE & CO | 1,553 | 1,316,260 | 0.0% |
| Hudson Bay Capital Management LP | 1,229 | 1,041,560 | 0.01% |
| Sculptor Capital LP | 819 | 694,649 | 0.02% |
| VANGUARD GROUP INC | 760 | 644,153 | 0.0% |
| Two Seas Capital LP | 691 | 585,602 | 0.15% |
| BANK OF AMERICA CORP /DE/ | 184 | 156,282 | 0.0% |
| GEODE CAPITAL MANAGEMENT, LLC | 159 | 135,209 | 0.0% |
| MORGAN STANLEY | 158 | 134,034 | 0.0% |
| STATE STREET CORP | 109 | 92,878 | 0.0% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 73 | 62,035 | 0.19% |
| Calamos Advisors LLC | 66 | 56,196 | 0.0% |
| WELLS FARGO & COMPANY/MN | 62 | 53,138 | 0.0% |
| GOLDMAN SACHS GROUP INC | 39 | 33,888 | 0.0% |
| NATIONAL BANK OF CANADA /FI/ | 29 | 27,731 | 0.0% |
| NORTHERN TRUST CORP | 24 | 21,140 | 0.0% |
| TWO SIGMA INVESTMENTS, LP | 15 | 13,320 | 0.0% |
| BOOTHBAY FUND MANAGEMENT, LLC | 13 | 11,038 | 0.0% |
| CastleKnight Management LP | 12 | 10,785 | 0.0% |
| CITIGROUP INC | 4 | 3,717 | 0.0% |
| ROYAL BANK OF CANADA | 1 | 859 | 0.0% |
| Allworth Financial LP | 0 | 10 | 0.0% |
| Point72 Asset Management, L.P. | 0 | 4 | 0.0% |